|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar
|
|
2
|
Hummel S, Simpson EL, Hemingway P, et al:
Intensity-modulated radiotherapy for the treatment of prostate
cancer: a systematic review and economic evaluation. Health Technol
Assess. 14:1–108. iii–iv
|
|
3
|
Alicikus ZA, Yamada Y, Zhang Z, et al:
Ten-year outcomes of high-dose, intensity-modulated radiotherapy
for localized prostate cancer. Cancer. 117:1429–1437
|
|
4
|
Michalski JM, Winter K, Purdy JA, et al:
Toxicity after three-dimensional radiotherapy for prostate cancer
on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys.
62:706–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zelefsky MJ, Kuban DA, Levy LB, et al:
Multi-institutional analysis of long-term outcome for stages T1–T2
prostate cancer treated with permanent seed implantation. Int J
Radiat Oncol Biol Phys. 67:327–333. 2007.PubMed/NCBI
|
|
6
|
Tward JD, Lee CM, Pappas LM, et al:
Survival of men with clinically localized prostate cancer treated
with prostatectomy, brachytherapy or no definitive treatment:
impact of age at diagnosis. Cancer. 107:2392–2400. 2006. View Article : Google Scholar
|
|
7
|
Chauveinc L, Osseili A, Flam T, et al:
Iodin 125 seed migration after prostate brachytherapy: a study of
170 patients. Cancer Radiother. 8:211–216. 2004.(In French).
|
|
8
|
Moosmayer D, Berndorff D, Chang CH, et al:
Bispecific antibody pretargeting of tumor neovasculature for
improved systemic radiotherapy of solid tumors. Clin Cancer Res.
12:5587–5595. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kao J, Stone NN, Lavaf A, et al: (125)I
monotherapy using D90 implant doses of 180 Gy or greater. Int J
Radiat Oncol Biol Phys. 70:96–101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taira AV, Merrick GS, Butler WM, et al:
Long-term outcome for clinically localized prostate cancer treated
with permanent interstitial brachytherapy. Int J Radiat Oncol Biol
Phys. 79:1336–1342. 2011.PubMed/NCBI
|
|
11
|
Stone NN, Potters L, Davis BJ, et al:
Multicenter analysis of effect of high biologic effective dose on
biochemical failure and survival outcomes in patients with Gleason
score 7–10 prostate cancer treated with permanent prostate
brachytherapy. Int J Radiat Oncol Biol Phys. 73:341–346.
2009.PubMed/NCBI
|
|
12
|
Mortazavi SM, Asadollahi S, Farzan M, et
al: (32)P colloid radiosynovectomy in treatment of chronic
haemophilic synovitis: Iran experience. Haemophilia. 13:182–188.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gao W, Liu L, Liu ZY, et al: Intratumoral
injection of 32P-chromic phosphate in the treatment of implanted
pancreatic carcinoma. Cancer Biother Radiopharm. 25:215–224. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zubillaga MB, Boccio JR, Nicolini JO, et
al: Use of colloids of chromic [32P] phosphate in treatment of
solid tumors. Nucl Med Biol. 23:907–910. 1996.
|
|
15
|
Alimi KA, Firusian N and Dempke W: Effects
of intralesional 32-P chromic phosphate in refractory patients with
head and neck tumours. Anticancer Res. 27:2997–3000.
2007.PubMed/NCBI
|
|
16
|
Zubillaga MB, Boccio JR, Nicolini JO, et
al: Great particles [32P]chromic phosphate for treatment of solid
tumors. Acta Physiol Pharmacol Ther Latinoam. 46:103–110. 1996.
|
|
17
|
Zubillaga M, Boccio J, Nicolini J, et al:
Brachytherapy of solid tumors. Use of chromic phosphate colloid.
Acta Physiol Pharmacol Ther Latinoam. 47:179–185. 1997.(In
Spanish).
|
|
18
|
Kang Y, Yin G, Ouyang P, et al:
Preparation of PLLA/PLGA microparticles using solution enhanced
dispersion by supercritical fluids (SEDS). J Colloid Interface Sci.
322:87–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teupe C, Meffert R, Winckler S, et al:
Ciprofloxacin-impregnated poly-L-lactic acid drug carrier. New
aspects of a resorbable drug delivery system in local antimicrobial
treatment of bone infections. Arch Orthop Trauma Surg. 112:33–35.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pandey A and Aswath P: Indentation creep
reservoirs for drug-eluting poly(L-lactic acid) scaffolds. J
Biomater Sci Polym Ed. 22:1591–1606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang M, Xu Y, Pan D, et al: Bioevaluation
of a novel [32P]-CP-PLLA microparticle for pancreatic cancer
treatment. Drug Dev Res. 71:364–370. 2010.
|
|
22
|
Finucane CM, Murray I, Sosabowski JK, et
al: Quantitative accuracy of low-count SPECT imaging in phantom and
in vivo mouse studies. Int J Mol Imaging. 2011:1973812011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng L, Jones TD, Lin H, et al:
Lymphovascular invasion is an independent prognostic factor in
prostate adenocarcinoma. J Urol. 174:2181–2185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gellman G, Healey G and Qingsheng C: The
effect of very low dose irradiation on restenosis following balloon
angioplasty. A study in the atherosclerotic rabbit. Circulation.
84(Suppl II): 46A–59A. 1991.
|
